Grants and Contributions:
Title:
UK Multisector - BioM - EXPEDITE SAVeP: Expediting the self-amplifying nucleic acid vaccine preclinical process
Agreement Number:
1035592
Agreement Value:
$455,000.00
Agreement Date:
Sep 1, 2025 - Nov 30, 2026
Description:
The collaboration aims to streamline a self-amplifying nucleic acid vaccine validation and accelerate the progression from preclinical to clinical trials.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6C 0A3
Reference Number:
172-2025-2026-Q3-1035592
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
732113931
Recipient Type:
For-profit organization
Recipient's Operating Name:
Eyam Health Inc.
Recipient's Legal Name:
EYAM HEALTH INC.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710